These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30811600)

  • 1. Availability and safety of blood transfusion in low- and middle-income countries.
    Smit Sibinga CT; Abdella YE
    Transfusion; 2019 Jun; 59(6):2155-2157. PubMed ID: 30811600
    [No Abstract]   [Full Text] [Related]  

  • 2. The global need and availability of blood products: a modelling study.
    Roberts N; James S; Delaney M; Fitzmaurice C
    Lancet Haematol; 2019 Dec; 6(12):e606-e615. PubMed ID: 31631023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood transfusion - safety of the inventory].
    Tissot JD; Danic B; Schneider T
    Presse Med; 2015 Feb; 44(2):178-88. PubMed ID: 25592756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems and Approaches for Blood Transfusion in the Developing Countries.
    Roberts DJ; Field S; Delaney M; Bates I
    Hematol Oncol Clin North Am; 2016 Apr; 30(2):477-95. PubMed ID: 27040966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug use in blood donors].
    Berg JA; Schjøtt J
    Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century.
    Glynn SA; Busch MP; Dodd RY; Katz LM; Stramer SL; Klein HG; Simmons G; Kleinman SH; Shurin SB;
    Transfusion; 2013 Feb; 53(2):438-54. PubMed ID: 22690676
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood transfusion and supply chain management safety].
    Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
    Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: a NHLBI workshop.
    Custer B; Zou S; Glynn SA; Makani J; Tayou Tagny C; El Ekiaby M; Sabino EC; Choudhury N; Teo D; Nelson K; Peprah E; Price L; Engelgau MM
    Transfusion; 2018 May; 58(5):1307-1317. PubMed ID: 29542130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety.
    Teo D
    Biologicals; 2012 May; 40(3):169. PubMed ID: 22507451
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemovigilance: an effective tool for improving transfusion practice.
    de Vries RR; Faber JC; Strengers PF;
    Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
    Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
    Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemovigilance drives improved transfusion safety.
    Murphy MF
    Transfusion; 2021 Apr; 61(4):1333-1335. PubMed ID: 33831223
    [No Abstract]   [Full Text] [Related]  

  • 13. Efforts Toward Elimination of Infectious Agents in Blood Products.
    Jacquot C; Delaney M
    J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.
    Bloch EM; Vermeulen M; Murphy E
    Transfus Med Rev; 2012 Apr; 26(2):164-80. PubMed ID: 21872426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Emerging Infectious Diseases on Chinese Blood Safety.
    He M; Wang J; Chen L; Liu J; Zeng P
    Transfus Med Rev; 2017 Apr; 31(2):94-101. PubMed ID: 27923518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International challenges of self-sufficiency in blood products.
    Dhingra N
    Transfus Clin Biol; 2013 May; 20(2):148-52. PubMed ID: 23643329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood drought in context.
    Raykar NP; Kralievits K; Greenberg SL; Gillies RD; Roy N; Meara JG
    Lancet Glob Health; 2015 Apr; 3 Suppl 2():S4-5. PubMed ID: 25926320
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of scarce resources in blood services in developing countries.
    Martínez MC
    Vox Sang; 2002 Aug; 83 Suppl 1():137-40. PubMed ID: 12617123
    [No Abstract]   [Full Text] [Related]  

  • 19. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD).
    WHO Expert Group
    Vox Sang; 2012 Nov; 103(4):337-42. PubMed ID: 22690746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings.
    Ware AD; Jacquot C; Tobian AAR; Gehrie EA; Ness PM; Bloch EM
    Vox Sang; 2018 Jan; 113(1):3-12. PubMed ID: 29193128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.